21.05.2024 11:20:15 - dpa-AFX: Sanofi, OpenAI To Build AI Software To Boost Drug Development

PARIS (dpa-AFX) - French drug major Sanofi is teaming with artificial
intelligence or AI startup OpenAI, the developer of highly popular generative AI
chatbot ChatGPT, as well as Formation Bio, an AI and tech-driven drug developer,
to build AI-powered software to accelerate drug development and bring new
medicines more efficiently.

With the AI collaboration, the companies expect to lead drug developers' way to
use the significant potentially positive impact of AI for patients waiting for
new treatments.

Under the deal, the companies would bring together data, software and tuned
models to develop custom, purpose-built solutions across the drug development
lifecycle. It's a first-of-its kind collaboration within the pharma and life
sciences industries.

Sanofi said it will leverage the partnership to provide access to proprietary
data to develop AI models as it aims to becoming the first biopharma company
powered by AI at scale.

Further, OpenAI, which is backed by tech giant Microsoft Corp., will contribute
access to cutting-edge AI capabilities, including the ability to fine-tune
models, deep AI expertise and dedicated thought partnership and resources.

Formation Bio will provide extensive engineering resources, and experience
operating at the intersection of pharma and AI. It will also provide its
tech-driven development platform to design, develop and deploy AI technologies
across all aspects of the pharma lifecycle.

Sanofi CEO Paul Hudson said, 'This unique collaboration is the next significant
step in our journey to becoming a pharmaceutical company substantially powered
by AI. Next generation, first-of-its kind AI model customizations will be an
important foundation in our efforts to shape the future of drug development for
pharma and for the many patients waiting for innovative treatments.'

Brad Lightcap, COO, OpenAI, added that there is massive potential for AI to
accelerate drug development, and that the collaboration would help patients and
their families by bringing new medicines to the market.

OpenAI last week enetred into a deal with social media company Reddit Inc. to
bring its content to ChatGPT and its products. OpenAI also agreed to become a
Reddit advertising partner.

Bloomberg recently reported that tech giant Apple Inc. is in the final stages of
reaching an agreement with OpenAI to incorporate ChatGPT features into iOS 18.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
SANOFI SA INHABER EO 2 920657 Xetra 89,010 03.06.24 13:13:38 -0,770 -0,86% 88,900 88,950 88,320 89,780
MICROSOFT DL-,00000625 870747 Xetra 384,000 03.06.24 13:39:32 +8,750 +2,33% 383,850 384,100 384,750 375,250

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH